Formycon AG (ETR:FYB)
Germany · Delayed Price · Currency is EUR 22.60
+1.30 (6.10%)
May 29, 2026, 5:35 PM CET
Formycon AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 52.28 | 44.48 | 69.67 | 77.7 | 42.5 | 36.61 | |
Revenue Growth (YoY) | -13.91% | -36.17% | -10.32% | 82.83% | 16.07% | 6.76% |
Cost of Revenue | 42 | 40.9 | 54.84 | 54.39 | 30.43 | 26.5 |
Gross Profit | 10.28 | 3.58 | 14.83 | 23.31 | 12.07 | 10.11 |
Selling, General & Admin | 20.31 | 20.31 | 21.39 | 14.12 | 12.17 | 7.13 |
Research & Development | 8.07 | 12.67 | 16.5 | 9.16 | 16.91 | 16.81 |
Other Operating Expenses | 0.09 | 1.09 | 0.49 | 0.39 | - | 0.17 |
Operating Expenses | 28.44 | 34.04 | 38.3 | 24.12 | 29.08 | 24.11 |
Operating Income | -18.16 | -30.46 | -23.47 | -0.82 | -17.01 | -14 |
Interest Expense | -3.12 | -3.12 | -1.09 | -0.08 | -0.13 | -0.04 |
Interest & Investment Income | 2.09 | 2.09 | 3.6 | 2.82 | 0.3 | 0 |
Earnings From Equity Investments | -16.66 | -16.66 | -15.17 | -19.36 | 76.84 | 0 |
Currency Exchange Gain (Loss) | -0.12 | -0.12 | 0.06 | -0.09 | 0.09 | -0.04 |
Other Non Operating Income (Expenses) | -5.37 | 0.03 | -0.02 | -0.01 | -0.02 | -0.13 |
EBT Excluding Unusual Items | -41.34 | -48.24 | -36.09 | -17.55 | 60.09 | -14.21 |
Merger & Restructuring Charges | - | - | - | - | -0.72 | - |
Impairment of Goodwill | - | - | -44.53 | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | 96.62 | -22.77 | - |
Asset Writedown | -59.6 | -59.6 | -84.72 | - | - | - |
Other Unusual Items | 17.35 | 17.35 | 21.09 | - | - | - |
Pretax Income | -83.6 | -90.5 | -144.25 | 79.07 | 36.6 | -14.21 |
Income Tax Expense | -26.7 | -25.8 | -18.58 | 3.28 | 0.6 | -0.92 |
Net Income | -56.9 | -64.7 | -125.67 | 75.8 | 35.99 | -13.29 |
Net Income to Common | -56.9 | -64.7 | -125.67 | 75.8 | 35.99 | -13.29 |
Net Income Growth | - | - | - | 110.59% | - | - |
Shares Outstanding (Basic) | 18 | 18 | 17 | 16 | 14 | 11 |
Shares Outstanding (Diluted) | 18 | 18 | 17 | 16 | 14 | 11 |
Shares Change (YoY) | 0.49% | 1.00% | 8.99% | 15.59% | 25.73% | 7.91% |
EPS (Basic) | -3.22 | -3.66 | -7.18 | 4.76 | 2.62 | -1.20 |
EPS (Diluted) | -3.22 | -3.66 | -7.18 | 4.72 | 2.59 | -1.20 |
EPS Growth | - | - | - | 82.24% | - | - |
Free Cash Flow | -4.55 | 10.05 | -24.77 | -10.88 | -19.43 | -13.75 |
Free Cash Flow Per Share | -0.26 | 0.57 | -1.42 | -0.68 | -1.40 | -1.25 |
Gross Margin | 19.66% | 8.04% | 21.29% | 30.00% | 28.41% | 27.61% |
Operating Margin | -34.74% | -68.49% | -33.68% | -1.05% | -40.03% | -38.24% |
Profit Margin | -108.84% | -145.46% | -180.37% | 97.55% | 84.69% | -36.30% |
Free Cash Flow Margin | -8.71% | 22.59% | -35.55% | -14.00% | -45.72% | -37.55% |
EBITDA | 11.81 | -4.82 | -15.11 | -0.21 | -16.31 | -13.33 |
EBITDA Margin | 22.59% | -10.83% | -21.69% | -0.27% | -38.37% | -36.42% |
D&A For EBITDA | 29.97 | 25.65 | 8.35 | 0.6 | 0.71 | 0.67 |
EBIT | -18.16 | -30.46 | -23.47 | -0.82 | -17.01 | -14 |
EBIT Margin | -34.74% | -68.49% | -33.68% | -1.05% | -40.03% | -38.24% |
Effective Tax Rate | - | - | - | 4.14% | 1.65% | - |